| GILENIA NOVARTIS AG
1364879 24 Sep 2007 | on 16 Oct 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries. | | | GILENIA NOVARTIS AG
1100683 24 Apr 2001 | on 14 Nov 2007 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of disorders of the central nervous system, and of the musculo skeletal system. | | | GILENIA & DESIGN NOVARTIS AG
1382281 06 Feb 2008 | on 26 Feb 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the prevention and treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, namely disorders of the thyroid and endocrine glands; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, hematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; antibiotics; pharmaceutical preparations for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations. | |